New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Protara Therapeutics, Inc.
TARA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

35M

Biotechnology

Next Earning date - 01 Nov 2024

35M

Biotechnology

Next Earning date - 01 Nov 2024

1.68USD
Shape0.06 ( 3.70%)
favorite-chart

Relative Strenght

21
favorite-chart

Volume Buzz

3%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

68%

Quote Panel

Shape
Updated October 12, 2024
1W -4.55 % 1M -10.64 % 3M -29.41 % 1Y 1.82 %

Key Metrics

Shape
  • Market Cap

    34.66M


  • Shares Outstanding

    20.63M


  • Share in Float

    18.41M


  • Dividende

    0


  • Earning Date

    01 Nov 2024


  • Price Target

    1.68


  • Average Volume

    146903


  • Beta

    1.845


  • Range

    1.04-5.24


  • Industry

    Biotechnology


  • Website

    https://www.protaratx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

28.69x

P/S Ratio

0.39x

P/B Ratio

0.1

Debt/Equity

-3368.3%

Net Margin

$-3.0

EPS

How TARA compares to sector?

P/E Ratio

Relative Strength

Shape

TARA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$25M

ShapeNaN%

2025-Revenue

$2.17

Shape-381%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.68
vs -0.96

Q4.22

arrow
arrow

N/A

-0.84
vs -0.91

Q1.23

arrow
arrow

N/A

-0.80
vs -0.96

Q2.23

arrow
arrow

N/A

-1.00
vs -0.80

Q3.23

arrow
arrow

N/A

-0.87
vs -0.68

Q4.23

arrow
arrow

N/A

-0.90
vs -0.84

Q1.24

arrow
arrow

N/A

-0.97
vs -0.80

Q2.24

arrow
arrow

N/A

-0.45
vs -1.00

Q3.24

arrow
arrow

N/A

-0.52
vs -0.87

Q4.24

arrow
arrow

N/A

-0.54
vs -0.90

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

1.2M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.06

Q4.22

arrow
arrow

-38%

-0.38
vs -0.05

Q1.23

arrow
arrow

-9%

-0.09
vs -0.38

Q2.23

arrow
arrow

-13%

-0.13
vs -0.09

Q3.23

arrow
arrow

-13%

-0.13
vs -0.13

Q4.23

arrow
arrow

-15%

-0.15
vs -0.13

Q1.24

arrow
arrow

-19%

-0.19
vs -0.15

Q2.24

arrow
arrow

-10%

-0.10
vs -0.19

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

30

30
vs 32

-6%

Q4.22

arrow
arrow

31

31
vs 30

3%

Q1.23

arrow
arrow

29

29
vs 31

-6%

Q2.23

arrow
arrow

30

30
vs 29

3%

Q3.23

arrow
arrow

32

32
vs 30

7%

Q4.23

arrow
arrow

32

32
vs 32

NA

Q1.24

arrow
arrow

39

39
vs 32

22%

Q2.24

arrow
arrow

42

42
vs 39

8%

Earnings Growth

Latest News